MedImmune, the global biologics research and development arm of AstraZeneca, and The University of Manchester have entered into a new research collaboration to generate cutting-edge protein formulation science.
from The Medical News http://ift.tt/1D0Xb5I
from The Medical News http://ift.tt/1D0Xb5I
No comments:
Post a Comment